Skip to main content

UBS Group AG

Position in HCAT — Health Catalyst, Inc.

CIK 1610520 ZURICH, V8

Position in HCAT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$364,610
-$265,122 QoQ
Shares Held
287,095
+9.0% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.81469548407321.ToString("F0")% Shared 0.ToString("F0")% None 0.18530451592678382.ToString("F0")%

Common Shares in HCAT Over Time

Shares Held

Position Value (USD)

Derivatives in HCAT

reported options exposure · as of Mar 31, 2025
CallValue
$2,042,740
CallShares
450,936
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Health Information Services

Healthcare · as of Mar 31, 2026

UBS Group AG holds $592,914,921 across 45 Health Information Services names. HCAT ranks #30 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HCAT

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $364,610 287,095
2025-12-31 $629,732 263,487
2025-09-30 $562,344 197,314
2025-06-30 $676,439 179,427
2025-03-31 $819,236 180,847
2025-03-31 $2,042,740 450,936
2024-12-31 $17,711,764 2,505,200
2024-12-31 $1,613,762 228,255
2024-09-30 $20,392,328 2,505,200
2024-09-30 $841,130 103,333
2024-06-30 $16,008,228 2,505,200
2024-06-30 $700,976 109,699
2024-03-31 $18,864,156 2,505,200
2024-03-31 $1,144,469 151,988
2023-12-31 $936,694 101,155
2023-09-30 $656,897 64,911
2023-06-30 $528,750 42,300
2023-03-31 $294,829 25,264
2022-12-31 $262,794 24,722
2022-09-30 $59,412 6,125
2022-06-30 $48,164 3,324
2022-03-31 $610,003 23,345
2021-12-31 $1,813,881 45,782
2021-09-30 $769,853 15,394
2021-06-30 $539,057 9,711
2021-03-31 $1,437,334 30,732
2020-12-31 $1,442,322 33,134
2020-09-30 $243,353 6,649
2020-06-30 $217,403 7,453
2020-03-31 $475,275 18,175